Sunnybrook Health Sciences Centre: Depression trials

The registry lists 23 Depression studies with Sunnybrook Health Sciences Centre as lead sponsor. 4 are open to participants now and 0 have results posted.

Early Phase 1 1Phase 1 2Phase 2 2Phase 3 2Phase 4 4No phase 13(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• InTRavenous kEtAmine and immerSive virtUal Reality to Treat dEpressionRecruitingNCT06781697Phase 3
• qEEG Brain Signature of Depression & Neuromodulation-induced RecoveryRecruitingNCT06719427Phase 1
• A Randomized Neuroimaging Trial of Psilocybin in DepressionRecruitingNCT06072898Phase 2
• Meditation and Biofeedback to Improve Anxiety, Depression and Quality of Life in Inpatients After StrokeRecruitingNCT05845541Not applicable
• Finding a Biomarker for Acute Neuromodulation Effects in Adolescent DepressionStatus unknownNCT05832294Not applicable
• Virtual Mindfulness Intervention RCTCompletedNCT05374213Not applicable
• Pilot Study of the Safety and Tolerability of L-DLPFC iTBS rTMS for MDD in MSStatus unknownNCT04621708Not applicable
• Virtual Reality to Reduce Pre-procedure Anxiety Prior ECTCompletedNCT04291196Not applicable
• Investigation of the Effects of Repetitive Transcranial Magnetic Stimulation on Cognition in DepressionCompletedNCT03977038
• Ultra-Brief Intervention to Reduce Depressive and Anxious SymptomsStatus unknownNCT03293797Not applicable
• Abbreviating Mindfulness-Based Therapy for Depressive and Anxious SymptomsCompletedNCT02861066Not applicable
• Mindfulness-Based Therapy for Brain Tumour SurvivorsCompletedNCT02792608Not applicable
• Effect of Ketamine vs. Active Placebo on Suicidal Ideation in Depressed Inpatients With Major Depressive Disorder or Bipolar Depression.CompletedNCT02593643Early Phase 1
• Group Treatment for Adolescents With DepressionTerminatedNCT02115737Not applicable
• Post-stroke Triage "DOC": Simple Screening for Depression, Obstructive Sleep Apnea and Cognitive ImpairmentCompletedNCT02007265
• Mental Health Telemetry for Self-Management in Major DepressionCompletedNCT01999010Not applicable
• Study of Placebo Without Deception Versus Standard Antidepressant for Major Depressive DisorderTerminatedNCT01650740Not applicable
• Risperidone vs. Olanzapine as add-on Treatment in Treatment Resistant DepressionCompletedNCT01282632Phase 1/2
• Treating Depression in Coronary Artery Disease With Omega-3 Fatty AcidsCompletedNCT00981383Phase 3
• Identifying Very Early Response to Seroquel Extended Release (XR) Augmentation for Major Depressive DisorderCompletedNCT00892463Phase 4
• Maintenance Study for Adolescent DepressionCompletedNCT00508859Phase 4
• The Role of Cytokine-Serotonin Interactions in Post-Stroke DepressionCompletedNCT00254020Phase 4
• Depression and Traumatic Brain InjuryCompletedNCT00254007Phase 4